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Susceptibility to infection by the human polyomavirus, JCV, is determined by intracellular mechanisms which control
transcription and replication. Originally thought to propagate well only in human cells of oligodendroglial lineage, JCV has
recently been shown to infect astrocytes, astrogliomas, and a neuroblastoma cell line. The data reported here describe
two cell types that have been subcultured from a human neuroblastoma cell line, SK-N-SH. The SH-SY5Y subclone displays
neuronal phenotypes and is not susceptible to JCV infection, while the SH-EP subclone displays glial cell phenotypes and
is susceptible to infection. Binding of nuclear proteins from the permissive SH-EP cells to the nuclear factor-1 (NF-1) site
in the JCV regulatory DNA sequences results in a gel shift pattern that is different from the nonpermissive SH-SY5Y cell
proteins. Northern analysis of mRNA for the four classes of NF-1 proteins showed a predominance of the NF-1/X class in
SH-EP cells similar to the highly permissive human fetal glial cells. Very low levels of mRNA for NF-1/X were seen in the
nonpermissive SH-SY5Y cells, similar to that seen for the nonpermissive HeLa cells. Several other cell lines tested that
were permissive for JCV infection also showed synthesis of the NF-1/X class of proteins. SH-EP cells represent a cell line
in a glial cell lineage which is susceptible to JCV multiplication. These cells may be a useful cell culture system for the
investigation of DNA binding factors which correlates with viral susceptibility. q 1997 Academic Press
INTRODUCTION reported that the human neuroblastoma cell line (IMR-32)
was susceptible to JCV infection (Akatani et al., 1994).
The human polyomavirus JC virus (JCV) is the etiologic In this report we examined JCV susceptibility of the
agent of the human demyelinating disease, progressive human neuroblastoma cell line SK-N-SH, two of its sub-
multifocal leukoencephalopathy (PML), a condition re- clones SH-EP and SH-SY5Y, and the GOTO and IMR-32
sulting from direct lytic infection of the myelin-producing cell lines (Sekiguchi et al., 1979; Tumilowicz et al., 1970).
oligodendrocytes in the central nervous system (CNS) The SK-N-SH neuroblastoma cell line is of particular in-
(Astrom et al., 1958). Seroepidemiologic surveys of the terest since it is composed of several phenotypes that
human population indicate that JCV infection is very com- include N- (neuronal) and S- (glial) type cells (Biedler et
mon and occurs worldwide (Walker et al., 1983). Despite al., 1978; Ross et al., 1983). Clonal subtypes have been
this prevalence, PML occurs predominantly in immuno- isolated from the parent SK-N-SH cell line. SH-SY5Y be-
compromised patients (Brown, 1975; Rziha, 1978; Padgett longs to the N-type which has neuroblast characteristics
and Walker, 1983). However the site of JCV latency in such as neurotransmitter biosynthetic enzyme activities
individuals remains unclear. Recent evidence suggests and catecholamine uptake (Ross et al., 1983; Rettig et
bone marrow involvement as well as the kidney as proba- al., 1987; Ciccarone et al., 1989; Tsokos et al., 1989; Gross
ble sites of viral latency (Major et al., 1992). et al., 1992). SH-EP cells are similar to immature glial
Since its isolation in 1971 from brain tissue of a PML cells (S type), since they are not neuronal but do produce
patient, JCV is propagated most efficiently in human fetal type I and III collagens (Ross, 1983; Rettig et al., 1987;
glial cells (HFGC) (Padgett et al., 1971). Two human fetal Ciccarone et al., 1989; Tsokos et al., 1989; Gross et al.,
glial cell lines, SVG and POJ (Major et al., 1985; Mandl et 1992). Since the restricted tropism of JCV both in vivo
al., 1987) (human fetal astrocytes immortalized by SV40 T and in vitro is most likely due to tissue-specific transcrip-
protein or JCV T protein, respectively) are also susceptible tion and replication factors that interact with the regula-
to JCV infection. Other cell types such as human fetal tory region, we further compared the DNA binding pro-
Schwann cells and the B lymphoma cell lines, Namalwa teins to domain B of the viral regulatory region using
and BJA-B, support only limited JCV multiplication. (Assou- nuclear extracts from permissive and nonpermissive cell
line and Major, 1991; Atwood et al., 1992). Recently, Akatani lines. In this paper we describe a permissive cell line
having an immature glial cell phenotype which has differ-
ent DNA protein binding characteristics to the JCV regu-1 To whom correspondence and reprint requests should be ad-
dressed. E-mail eomajor@codon.nih.gov. Fax: 301-594-5799. latory region compared to nonpermissive cells.
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MATERIALS AND METHODS and the HindIII site of pCR-Script (SK) vector was cloned
into the HindIII site of promoterless plasmid pCAT-Basic
Virus and cells Vector (Promega). JC virus minimal regulatory region was
cloned into pCR-Script (SK) vector using oligonucleotidesThe 586 strain of JCV (JCV 586) was recovered from
of annealed primers COR TOP 5* TCTAGATTTTTTTAT-owl monkey tumor cells (Major et al., 1987) and maintains
ATATACAGGAGGCCGAGGCATGC3 * and COR BOT 5*a Mad-4 regulatory region genotype (Major et al., 1987).
GCA TGC CTC GGC CTC CTG TAT ATA TAA AAA AAT C T-U87-MG, SK-N-SH, IMR-32, and HeLa cells were pur-
AGA3 *. The fragment between the SphI site within thechased from the American Type Culture Collection
primers and the HindIII site of the vector was cloned into(ATCC, Rockville, MD). SH-EP and SH-SY5Y cells were
pCAT-Basic Vector. Transcription from the JCV promoterkindly provided Fabrizio Ensoli (National Cancer Institute,
is in the early orientation.Bethesda, MD). GOTO cells were purchased from the
The plasmid pAT1 was constructed by cloning theJapanese Cancer Research Resource Bank (JCRR). The
EcoRI fragment of the plasmid pBRNF-1AT-1 intoSVG cells were established as an astrocyte cell line de-
pcDNA3 (Invitrogen, Sumner et al., 1996).rived from human fetal brain which maintains susceptibil-
ity to JCV infection (Major et al., 1985). These cells were
Transient transfection and CAT assaycultured in Eagle’s minimal essential medium (MEM) or
RPMI 1640 supplemented with 10% fetal bovine serum Cells (6 1 105) were plated on a 60-mm plate and
(FBS), L-glutamine (3.0 mg/ml), and gentamicin. The cul- grown overnight. Three hours prior to transfection, the
tures were maintained with 5% CO2 at 377. cells were fed with new growth media. Transfections
were carried out with lipofectamin (Life Technologies).
Infection and virus passage
Extracts were prepared 48 hr after transfection. The pro-
tein concentration of the sample was determined by theVirus inoculations were carried out by the modified
method of Bradford (1976). Equal concentrations of pro-centrifugation–absorption method (Akatani et al., 1994).
tein were assayed for CAT enzyme activity using theForty hemaglutination (HA) units per milliliter of JCV were
fluor diffusion method of Neuman (1987). Briefly, 50 mgmixed with 1 1 106 cells in serum-free MEM and centri-
of protein, diluted in 250 mM Tris–HCL (pH 7.8) wasfuged for 1 hr at 3000 rpm at room temperature. The cells
added to a reaction mixture containing 0.25 mM chloram-were absorbed with the virus for 1 hr at 377, washed
phenicol and 0.5 mCi of 3H-acetyl coenzyme A (DuPont).once with MEM, and seeded into 35-mm plates (Costar,
The mix was then overlayed with 5.0 ml liquid scintillationCambridge, MA).
cocktail and counted in a b scintillation counter (Beck-For virus passage, infected cells were frozen and
man Instruments) for 2.5 hr. Efficiency of transfection wasthawed 31 and then treated with 0.05 mg/ml neurami-
monitored with pSV2-b-galactocidase control plasmiddase Type V (Sigma) for 16 hr. The infected cell lysates
(Promega) or by slot blot hybridization of DNA isolatedwere treated at 567 for 30 min and centrifuged at 1000g
from the transfected cells. Three independent trans-for 10 min. The final virus containing supernatant was
fection experiments were performed with duplicatequantitated by hemagglutination (HA of human type O
samples.erythrocytes) (Padgett et al., 1971) and used for virus
inoculations.
Immunocytochemical and immunofluorescent analysis
Plasmids
At various times after infection, cells were washed with
PBS and fixed for 5 min in acetone at 0207. CoverslipsThe plasmid pM1EHL CAT contains the regulatory re-
gion of the JCV Mad-1 strain (5113 to 298 bp). The plas- were then incubated with anti-SV40 T antigen antibody
(Pab 416, Oncogene Science, New York) and anti-SV40mid p586EHL CAT contains the regulatory region of the
JCV 586 strain and the plasmid pM1EH28 CAT contains VP-1 antibody (provided by Dr. L. Norkin) for 30 min at
377C. The coverslips were washed 31 in PBS and incu-the minimal regulatory region (1 to 28 bp) for the negative
control. The cloning procedures utilized the pCAT-Basic bated with secondary anti-mouse or anti-rabbit antibody
conjugated with biotin (Zymed) for 30 min. The complexVector (Promega) as follows: JC virus promoter was
cloned into pCR-Script (SK) vector by amplifying the plas- was incubated for 30 min with strepavidin–biotin,
washed, and then mixed with diaminobenzidine (DAB)mid pM1TC and pBRJCV586 as templates for the regula-
tory regions of either JCV Mad 1 strain or JCV 586 strain in the presence of H2O2 . T and V antigen-positive JCV-
infected cells were counted by light microscopic exami-respectively. The primers were LCS5*GACACGTCGA-
CTC CCT ATT CAG CAC TTT GTC CAC TTT A G CT3 * and nation. For immunofluorescent analysis, coverslips were
fixed with 50% methanol/50% acetone for 5 min at roomLCX 5 * GACAC - TC - TAGATACGTGACAGCTGGCGAAG -
AACCTTGGCCA3 *.The fragment which contains the JC temperature, incubated with antibodies, washed 31 with
PBS, and incubated with fluorescein-conjugated mousevirus regulatory region between the HindIII site of JCV
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TABLE 1or rabbit antibody for 30 min. Positive cells were counted
using a Zeiss, ICM 405 epiflourescent microscope. Yield of JCV in Neuroblastoma Cell Lines
Preparation of nuclear extracts JCV586
Cultures of human fetal glial cells, HeLa, SH-EP, and Cell lines Input HA HA titer a
SH-SY5Y were grown in 125-cm2 culture flasks (Corning).
IMR-32 40 2560Nuclear extracts were prepared by a modification of the
GOTO 40 320procedure of Schreiber (Schreiber et al., 1989). The pro-
U87-MG 40 8
tein concentration of the sample was determined by the SK-N-SH 40 2560
method of Bradford (1976). SH-EP b 40 10,240
SH-SY5Y b 40 2
HeLa 40 2Oligonucleotide probe and gel shift assays
The following oligonucleotides were synthesized by a 28 days after infection.
b Subclone of SK-N-SH.Gibco-BRL (Gaithersburg, MD). NF-134:5*-GATCTGGAA-
G GGATGGCT GCCA G CC AAGC ATGA-3 * and NF-
134m:5* - GATCTGGAAGGGATGGCTGCCAGCCAGCCA -
labeled probe was added to the hybridization solution.AGCATGA-3 *. Double-stranded oligonucleotides were
Hybridization was carried out at 557 for 20 hr. The filterlabeled with [g-32P]ATP. The labeled probe (11 104 cpm)
was washed in two changes of 21 SSC/0.1% SDS atwas incubated with 10 mg of nuclear extract in the pres-
room temperature for 15 min each and in two changesence or the absence of a 50-fold molar excess of an
of 0.21 SSC/0.1% SDS at 557 for 15 min each. After wash-unlabeled, homologous probe or an unlabeled mutant
ing, the filter was exposed to Kodak X-Omat film from 1probe. The DNA protein binding reaction also contained
to several days.10 mM Tris (pH 7.9), 50 mM NaCl, 5 mM MgCl2, 0.5 mM
EDTA, 1.0 mM DTT, 10% glycerol (v/v), and 4 mg of poly
RESULTS(dI-dC) (Pharmacia). The reaction was carried out at room
temperature for 15 min and electrophoresed through a JCV infection in human neuronal and glial tumor cell
6% polyacrylamide Tris– glycine gel. The gel was dried, lines
and samples were visualized by autoradiography follow-
Forty HA units of JCV 586 per 106 cells were inoculateding exposure of Kodak X-Omat film with an intensifying
into human neuroblastoma cell lines IMR-32, GOTO, andscreen for 24 hr.
SK-N-SH, the human glioma cell line U87-MG, and HeLa
cells. After 4 weeks there was no significant cytopatho-Probe
logic effect (CPE) in any of the infected cultures. Virus
A 464-bp 3 * probe was obtained from BSNF-A which production was determined by HA assay at 4 weeks
was subcloned by RT–PCR and then sequenced (Sum- postinfection. HA titers were normalized to 106 cells. The
ner et al., 1996). A 1547-bp 3 * probe was obtained from results are shown in Table 1: 2560 HA units in IMR-32;
NF-1/Red (ATCC) after digestion of the plasmid with 160 HA units to 320 HA units in GOTO; 2560 HA units in
EcoRI. A 1023-bp 3 * probe was obtained from pCTF1 SK-N-SH; 8 HA units in U87-MG; and 2 HA units (lysate
(kindly provided from Dr. Tijian) after digestion of the of 105 cells) in HeLa. The two subclones of the SK-N-SH
plasmid with Sal I and EcoRI. A 842-bp 3 * probe was cell line, SH-EP and SH-SY5Y, were also tested for JCV
obtained from pBRNF1/AT1 after digestion of the plasmid infectivity. Forty units per 106 cells of JCV 586 were inocu-
with Afl I and EcoRI. These fragments were purified from lated into SH-EP and SH-SY5Y and maintained for 4
agarose gel and were labeled with [32P]dCTP by the ran- weeks with no significant CPE. However, there was a
dom primer labeling method. significant difference in virus production between SH-EP
and SH-SY5Y: 10240 HA units per 106 cells in SH-EP but
Northern analysis 2 HA units of 106 cell lysate in SH-SY5Y (Table 1).
Total RNA was isolated by a modified single-step
Susceptibility in SH-EP compared with that of SVG
method of RNA isolation by acid–guanidium thiocya-
cells
nate–phenol–chloroform extraction (Chromczynski and
Sacchi, 1987). Twenty micrograms of total RNA was elec- The extent of JCV infection in SH-EP cells was com-
pared with SVG cells, an immortalized human fetaltrophoresed through a 1% formaldehyde gel and trans-
ferred to nylon filters. The filter was prehybridized in 50% astrocyte cell line (Major, 1985) and examined for virion
multiplication. JCV 586 was inoculated onto coverslips offormamide, 51 SSPE, 51 Denhardt’s, 100 mg/ml herring
sperm DNA, 0.1% SDS at 557 for 1 hr. Then a [P32]dCTP- SH-EP, SH-SY5Y, and SVG cells. At 1, 2, and 3 weeks
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FIG. 1. Immunocytochemical staining of SH-EP cells for T protein at 21 days postinoculation with JCV 586.
postinfection, coverslips were removed and fixed or cells SH-SY5Y cells at any time point. The extent of JCV multi-
plication from either SH-EP or SVG cells was comparablewere harvested for virus assays. Viral T and virion pro-
teins were analyzed using specific antibodies in immuno- as measured by the final HA titer as shown in Table 2.
cytochemical assays. Virion multiplication was tested by
HA assay. In the SH-EP cells, JCV T protein was detected Identification of antigenic phenotype of SH-EP
in 12.6% of the cells by 2 weeks. By 21 days postinfection
with JCV 586, 30.7% of SH-EP cells were stained for T We established the phenotype of SH-EP and SH-SY5Y
using immunofluorescent analysis with the following an-protein (Fig. 1) and 12.6% stained for V protein (Fig. 2).
However, there was no detectable virus production in tibodies: anti-NF, anti-GFA, anti-GC, anti-vimentin, O4,
FIG. 2. Immunocytochemical staining of SH-EP cells for V capsid protein at 21 days postinoculation with JCV 586.
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TABLE 2 tition with homologous, unlabeled NF-1 probe but not by
mutated NF-1 probe. In lane 10, nuclear extract fromKinetics of JCV 586 Virion Multiplication in SVG and SH-EP Cells
HeLa cells yielded much slower migrating bands. In lane
HA titer 7, the nuclear extracts from HFG resulted in faster but
slightly smeared migrating bands with a more intense
Days PI SH-EP SVG signal. In SH-EP and SH-SY5Y, NF-1-specific bands were
seen in lanes 1 and 4. There were strong signals in both7 2 1280
bands with a significant difference in the slower shifted14 5120 10,240
21 40,960 40,960 band. To clarify the difference between the shifted bands,
extended electrophoresis was performed under the
same conditions as shown in Fig. 3B. NF-1-shifted bands
and A2B5. SH-EP cells did not stain with antibodies to were seen in positions marked I to VI. Complexes gener-
GFA, NF, or GC but did react with vimentin and A2B5 ated with nuclear extracts from SH-EP cells demon-
antibodies. SH-SY5Y was positive for neurofilaments. strated two bands (I and III), whereas complexes from
This result confirms that SH-SY5Y has a neuronal pheno- SH-SY5Y cells had bands migrating at different positions
type, while SH-EP was not positive for neuronal, differen- (II and IV). HeLa cells demonstrated (V and VI).
tiated glial, and differentiated oligodendrocyte markers.
Expression of NF-1 mRNAHowever, the cells were positive for oligodendroglial pre-
cursor markers (data not shown). NF-1 DNA binding proteins consist of a family of pro-
teins which are categorized into four classes A, B, C, and
Difference in the binding protein for the regulation
D (Inoue et al., 1980; Paonessa et al., 1988; Gill et al.,
of JCV gene expression and replication in SH-EP
1988; Santoro et al., 1988; Apt et al., 1994). The amino-
and SH-SY5Y
terminal end of each class member contains the DNA
recognition site and is shared by all classes. The differentTo determine if there is a difference in DNA binding
proteins between SH-EP and SH-SY5Y that could ac- carboxy termini of the proteins separate the classes into
groups. We investigated whether the different shiftedcount for viral susceptibility, gel shift assays were per-
formed. We focused on domain B in the JCV regulatory bands correlate with the difference in NF-1 classes at
the mRNA level. Figure 4 shows the result of Northernregion which has been shown to be essential for viral
multiplication. We used the NF-1 binding site in domain analysis using probes specific for each class of NF-1
proteins. The reported size of the NF-1/A mRNAs are 8.6,B as a probe in the gel shift assay using nuclear protein
extracts from SH-EP, SH-SY5Y, HFG, and HeLa cells (Fig. 4.5, 4.3, 1.8, 1.7, 1.6, 0.95, and 0.6 kb depending upon
distribution in different tissues (Paonessa et al., 1988).3A). Specific gel-shifted bands were detected by compe-
FIG. 3. DNA binding profiles of NF-1 consensus sequence of JCV from SH-EP, SH-SY5Y, HeLa, and HFG cells. (A) Bandshift experiment using
an g-32P-labeled NF-1 binding site oligonucleotide with nuclear extracts from SHEP (1–3 lanes), SH-SY5Y (4–6 lanes), HFG (7–9 lanes), and HeLa
(10 –12 lanes). (B) Band shift experiment using an g-32P-labeled NF-1 binding site oligonucleotide under the same condition as with A, except longer
electrophoresis shows the shifted bands (I to VI). NS refers to a non-specific band.
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FIG. 4. NF-1 mRNA abundance in neuroblastoma cells. The Northern
blot filters contained 20 mg RNA from SK-N-SH (lane 1), SH-SY5Y (2),
SH-EP (3), GOTO (4) IMR-32 (5), HFG (6), and HeLa (7). Filters were
probed with random labeled fragments of the transcriptional domain FIG. 5. Northern analysis of NF-1/X mRNA in transient transfected
of NF-1/A (A), NF-1/B (B), NF-1/C (C), NF-1/X (D), and b-actin as the HeLa cells. Four micrograms of NF-1/X effector plasmid (pAT1) or
RNA concentration control. pcDNA3 was transfected into HeLa cells. Extracts were prepared 48
hr after transfection. The Northern blot filter contained 20 mg total RNA
from HFG (lane 1), HeLa transfected with the plasmid pcDNA3 (2), and
HeLa transfected with the plasmid pAT1 (3). Upper and lower arrowsEach cell line showed an 8.6-kb band. In addition, the
show the transcript which was detected by the NF-1/X-specific probe.GOTO cells also had migrating bands at 4.3 and 0.95 kb.
(Bottom) The transcript of actin as the RNA control.
Therefore, smaller bands in the GOTO cells would also
be specific for the NF-1/A mRNA. However, mRNA levels
were reduced in both SH-EP and SH-SY5Y cells; NF-1/B than the NF-1/X expressed in HFGC cells because of
mRNA was found in all cell lines. In SH-EP cells, how- the cDNA clone originally isolated (Sumner et al.,
ever, the NF-1/B 7.5-kb band was approximately 10-fold 1996). Reporter gene constructs using the CAT gene
less than the SH-SY5Y cells. The expression of the NF- (Fig. 6 and described under Materials and Methods)
1/C-CTF mRNA at 8.6 and 6.5 kb was found in HeLa cells were made using the JCV promoter preserving the NF-
but much reduced in SH-EP and SH-SY5Y cells. However, 1 binding sites. These constructs were transfected into
NF-1/D-X was expressed in IMR-32, SH-EP, and human HeLa cells either with or without the NF-1/X expression
fetal glial cells which are susceptible to JCV infection.
The NF-1/D-X was not detected in HeLa cells and was
low in SH-SY5Y cells; both cell types are not permissive
for JCV infection.
Transcriptional activation of the JCV early promoter
by NF-1/X in HeLa cells
In order to assess its functional significance, we
asked whether NF-1/X could activate the JCV early pro-
moter in a cell type that is nonpermissive to infection.
HeLa cells were selected since they are not permissive
to JCV and also do not express NF-1/X in significant
amounts. To be certain that NF-1/X could be expressed
in HeLa cells, Northern analysis was done following
transfection of an expression clone of NF-1/X made
from HFGC called AT-1 (Sumner et al., 1996). Figure 5
shows that the NF-1/X clone is expressed in HeLa cells FIG. 6. Schematic of promoter structure. Open boxes represent tan-
using the AT-1 containing vector as a probe (Sumner dem repeat sequences, the black box is the TATA box sequence, and
the arrowheads mark the NF-1 consensus sequence.et al., 1996). The AT-1 expression vector is smaller
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second repeat of the regulatory region which is 79 bp
because of the deletion of the TATA box sequences. As
a result of the TATA box deletions, protein interactions
may be changed at this NF-1 site. Interestingly, most
isolates of JCV from cell culture or from PML brain tissue
have the second TATA box sequence deleted. There is
no variant of JCV with alterations at either NF-1 site.
Consequently, NF-1 is thought to be important for suc-
cessful JCV infection. A number of studies have charac-
terized the NF-1 binding region of JCV, described as do-
main B, in the regulatory region (Tamura et al., 1988;
Amemiya et al., 1989, 1992; Kumar et al., 1993; Sock et
al., 1991). For example, there are reported differences in
gel shift patterns using NF-1 probes between susceptible
human fetal glial cells and nonpermisive HeLa cells
(Amemiya et al., 1989, 1992). A similar observation has
FIG. 7. Effect of NF-1/X on the transcriptional activity of JCV early been reported in gel shift assays using adenovirus from
promoter in HeLa cells. Two micrograms of p586EHL CAT, pM1 EHL site NF-1 as a probe with extracts from permissive epi-
CAT, and pM1 EH28 CAT were transfected into HeLa cells with 4 mg thelial cells compared with nonpermissive fibroblasts
of the NF-1/X effect plasmid or the parent plasmid pcDNA3. The bottom
(Apt et al., 1994).of the graph shows the fold activation over controls.
In this study, we found differences in gel shift pat-
terns between SH-EP and SH-SY5Y cells. In the gel
shift assay using oligonucleotide probes for NF-1,
vector. The early promoters from JCV 586 (Mad-4) and there were frequent heterogeneous and smeared
Mad-1 showed an 8.6- and 4.6-fold activation with the bands (Kruse, 1994; Altman et al., 1994; Apt et al.,
NF-1/X clone as demonstrated in Fig. 7. These data 1994). Explanations for this observed pattern with NF-
suggest that the NF-1/X plays an important role in posi- 1 probes have included: (1) phosphorylation of the
tively regulating JCV expression for permissiveness. binding proteins during cell growth (Yang et al., 1993);
(2) the fact that NF-1 consists of four different classes
with each NF-1 class demonstrating a different spliceDISCUSSION
form with different transcriptional activity (Apt et al.,
1994); and (3) a complex of multiple proteins affectsThe restricted tissue tropism of JCV is observed both
in vivo and in vitro. In vitro, JCV has been effectively the migration of the probe as reported with PC-12
cells (Adams et al., 1995). We conducted a similarpropagated in human fetal glial cells (Major et al.,
1992) and more recently in a neuroblastoma cell line assay as described using PC-12 cells. There was no
change in migration pattern of the gel-shifted bandsIMR-32 (Akatani et al., 1994). In this study, we found
that JCV was produced in several neuroblastoma cell making different complex of proteins unlikely (data
not shown). However, the expression of NF-1 mRNAlines, IMR-32, GOTO, and SK-N-SH. The latter has two
phenotypes, N-type (neuronal) and S-type (glial). We in SH-EP and SH-SY5Y is different (Fig. 4). Whether
there is a functionally dominant form of NF-1 in thefound that only the S-subtype (SH-EP) was susceptible
for JCV but not the N-type, nor the neuronal subclone glial phenotype of the neuroblastoma cell line is cur-
rently being investigated. Of the four classes of the(SH-SY5Y). The phenotype of the SH-EP cells did not
contain the differentiation markers of mature astro- NF-1 family of proteins, we have determined that the
NF-1/X or class D NF-1 mRNA is highly expressed incytes (GFAP) or oligodendrocytes, (galactose cera-
mide). SH-EP cells did express the A2B5 cell surface human fetal glial cells and barely detectable in HeLa
cells (Sumner et al., 1996). These data suggest thatmarker characteristic of immature or precursor glial
cells (Elder and Major, 1988). selective expression of a factor such as NF-1 may
correlate with successful infection of cells with JCV.The strain of JCV used in these experiments, JCV 586,
originated from an owl monkey-induced astrocytoma Biochemical characterization of NF-1 binding proteins
to JCV sequences in SH-EP cells and other permissive(Major et al., 1987) and has the JCV Mad-4 genotype.
This is similar to the IMR-32 adapted JCV which also has cells is currently underway. The experiments reported
here extend the host range for JCV to a novel cell linea Mad-4 type arrangement in its regulatory region (Yogo
et al., 1993). Interestingly, the Mad-4 regulatory region which may be used for JCV propagation. This cell line
may be useful in defining the molecular basis for JCVhas a conserved NF-1 consensus sequence which is
present in the first 98-bp ‘‘tandem repeat’’ as well as the glial tropism.
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